companydata.dkcompanydata.dk

OrfoNeuro ApS: Financial statements 2022

CVR: 37768901

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -90,228 and a net result of DKK -95,046 compared with DKK -88,316 the year before. Equity in the 2022 report amounted to DKK -599,412.

Gross Profit
DKK -90,228
Profit/Loss
DKK -95,046
Equity
DKK -599,412
Total Assets
DKK 52,973
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--90 t.-95 t.-599 t.0
2021--79 t.-88 t.-504 t.0
2020--155 t.-153 t.-416 t.0
2019--146 t.-140 t.-263 t.0
2018--204 t.-166 t.-123 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on OrfoNeuro ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

OrfoNeuro ApS: The 2021 annual report is outJul 4, 2022

OrfoNeuro ApS has published its annual report for 2021. Gross profit came to DKK -79,332, and the net result was DKK -88,316.

About OrfoNeuro ApS

OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.

Source: annual report 2025, Danish Business Authority